Page 186 - Aet News Today

Some providers are still hesitant about certain technology advancements, but this article shows not only how critical tech will be to the healthcare industry at large, but also how it can help to lessen the toll of unpredictable crises, like the pandemic or the insurmountable nursing shortage we're currently facing.

The continuous enrollment requirement, which barred states from disenrolling Medicaid members, will end March 31. About three-quarters of managed care plans anticipate 10% to 25% of their Medicaid enrollees losing coverage once the continuous enrollment provision ends.

Syena, the latest company formed by startup creator Replay, is developing cancer treatments based on a type of immune cell called a natural killer cell. This NK cell therapy technology, licensed from The University of Texas MD Anderson Cancer Center, could overcome many of the limitations facing first-generation cell therapy.

A new treatment under development by HeartPoint Global seeks to provide a minimally invasive and cheaper alternative to current treatments for pulmonary arterial hypertension.

Analysts predict that disruptors could own as much as 30% of the $260 billion primary care market by 2030. A recent report from the American Hospital Association outlines major moves the healthcare industry should be watching this year from disruptors like Amazon, CVS and Walgreens — from billion-dollar acquisitions of primary care companies to expanding clinic locations to efforts in the home care space.

Since the start of the Covid-19 pandemic, there has been a 23% increase in alcohol abuse and a 16% increase in drug abuse, and people in self-isolation reported a 26% higher consumption than usual, according to the National Library of Medicine. Some apps are trying to meet this need, including Sober Sidekick and SoberBuddy.

The funding round was led by Distributed Ventures and included participation from Idealab NY and Elements Health Ventures. Tuned plans to use the funding to contract with more employers and third party administrators, said Danny Aronson, co-founder and CEO of the startup.

G1 Therapeutics said its drug met the main goal of a Phase 3 study in colorectal cancer, but the preliminary results also show measures of survival are better in the placebo arm. The company is stopping the colorectal cancer study.

Intermountain Health recently struck a partnership with experience management company Qualtrics. The Salt Lake City-based health system is implementing Qualtrics’ platform across all its facilities to optimize research around the customer and employee experience.

GE HealthCare recently announced plans to acquire Caption Health, a company that sells AI software designed to guide cardiac imaging. The company's guidance technology aims to make ultrasound exams easier and faster, as well as allow a broader set of healthcare professionals to conduct basic echocardiography exams.